Search Results | Showing 1 - 10 of 11 results for "Brandon Capital" |
| | ... later, V-Ignite has been selected by the Victorian government to run its newly created VSCF alongside VC investor Brandon Capital Partners. V-Ignite is tasked with raising at least $60 million from private investors including super funds, family offices ... |
| | | ... firm has raised $11.7 million, led by the Medical Research Commercialisation Fund (MCRF), which is managed by Brandon Capital and other investment partners that includes federal government support via MCRF and superannuation funds. The preventative nasal ... |
| | | ... Respiratory raised $11.7 million from a coalition of institutional Australian investors in a capital raise led by Brandon Capital, a venture capital firm that manages the Medical Research Commercialisation Fund; Australia and New Zealand's largest life ... |
| | | ... private equity and early stage investment firms, including Blackbird Ventures ($160m), Carthona Capital ($50m), Brandon Capital ($40m), Siguler Guff ($20m) and M.H. Carnegie ($25m). "That makes Hostplus by the far the largest investor in venture capital ... |
| | | ... US$557.5 million. Fibrotech was an investee company of the Medical Research Commercialisation Fund managed by Brandon Capital Partners, with its investors comprising Australian Super, Statewide Super, HESTA, Hostplus and the Australian Government. In ... |
| | | ... development. This follows a long line of venture capital investments made by Hostplus, including commitments to Brandon Capital, Blackbird Ventures and Square Peg Capital. Speaking to the investment from Hostplus, Artesian managing partner Jeremy Colless ... |
| | | Brandon Capital will lead a group of venture capital firms tasked with managing the government's $500 million Biomedical Translation Fund (BTF). Brandon Capital will drive the development of its life sciences fund, the Medical Research Commercialisation ... |
| | | ... innovators, and then fund innovators," he said. Hostplus currently invests through a number of fund managers, including Brandon Capital Partners which invests solely in life sciences ventures and also counts Australian Super, HESTA and Statewide Super ... |
| | | ... treatments and technologies to the market. University backed incubator ATP Innovations and seed capital specialist Brandon Capital were behind three of the four medical devices to receive grants. The Brandon and ATP backed Elastagen received a $4 million ... |
| | | ... Sydney-based fund managers with a focus on technology, including: M.H. Carnegie & Co (general and medical technology), Brandon Capital Partners (biotech), and Blackbird Ventures (software). |
|